摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[3-[(2,6-二氯苯基)甲氧基]苯基]乙酮 | 202144-69-2

中文名称
1-[3-[(2,6-二氯苯基)甲氧基]苯基]乙酮
中文别名
——
英文名称
3-(2,6-dichlorobenzyloxy)acetophenone
英文别名
1-[3-[(2,6-Dichlorophenyl)methoxy]phenyl]ethanone
1-[3-[(2,6-二氯苯基)甲氧基]苯基]乙酮化学式
CAS
202144-69-2
化学式
C15H12Cl2O2
mdl
MFCD05624040
分子量
295.165
InChiKey
JRKNMXSIQXIBNM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.133
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:0a0f3978d027a1eadf3166046f77ab1e
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Calcium receptor active compounds
    申请人:NPS Pharmaceuticals, Inc.
    公开号:US20030176485A1
    公开(公告)日:2003-09-18
    A novel calcium receptor active compound having the formula is provided: Ar 1 —[CR 1 R 2 ] p —X—[CR 3 R 4 ] q —[CR 5 R 6 ]—NR 7 —[CR 8 R 9 ]—Ar 2 wherein: Ar 1 is selected from the group consisting of aryl, heteroaryl, bis(arylmethyl)amino, bis(heteroarylmethyl)amino and arylmethyl(heteroarylmethyl) amino; X is selected from the group consisting of oxygen, sulfur, sulfinyl, sulfonyl, carbonyl and amino; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are, for example, hydrogen or alkyl; Ar 2 is selected from the group consisting of aryl and heteroaryl; p is an integer of from 0 to 6, inclusive; and, q is an integer of from 0 to 14, inclusive.
    提供一种具有以下式子的新型钙受体活性化合物:Ar1—[CR1R2]p—X—[CR3R4]q—[CR5R6]—NR7—[CR8R9]—Ar2其中:Ar1选自芳基、杂芳基、双(芳基甲基)氨基、双(杂芳基甲基)氨基和芳基甲基(杂芳基甲基)氨基的群;X选自氧、硫、亚磺酰基、磺酰基、羰基和氨基的群;R1、R2、R3、R4、R5、R6、R7、R8和R9例如是氢或烷基;Ar2选自芳基和杂芳基的群;p为0至6的整数,包括0和6;q为0至14的整数,包括0和14。
  • Calcium receptor-active compounds
    申请人:NPS Pharmaceuticals, Inc.
    公开号:US20020107406A1
    公开(公告)日:2002-08-08
    A novel calcium receptor active compound having the formula is provided: Ar 1 —[CR 1 R 2 ] p —X—[CR 3 R 4 ] q —[CR 5 R 6 ]—NR 7 —[CR 8 R 9 ]—Ar 2 wherein: Ar 1 is selected from the group consisting of aryl, heteroaryl, bis(arylmethyl)amino, bis(heteroarylmethyl)amino and arylmethyl(heteroarylmethyl) amino; X is selected from the group consisting of oxygen, sulfur, sulfinyl, sulfonyl, carbonyl and amino; R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are, for example, hydrogen or alkyl; Ar 2 is selected from the group consisting of aryl and heteroaryl; p is an integer of from 0 to 6, inclusive; and, q is an integer of from 0 to 14, inclusive.
    提供了具有以下结构的一种新型钙受体活性化合物:Ar1—[CR1R2]p—X—[CR3R4]q—[CR5R6]—NR7—[CR8R9]—Ar2其中:Ar1选择自芳基、杂芳基、双(芳基甲基)氨基、双(杂芳基甲基)氨基和芳基甲基(杂芳基甲基)氨基的群;X选择自氧、硫、亚硫基、磺酰基、羰基和氨基的群;R1、R2、R3、R4、R5、R6、R7、R8和R9例如是氢或烷基;Ar2选择自芳基和杂芳基的群;p是从0到6的整数,包括0和6;q是从0到14的整数,包括0和14。
  • CALCIUM RECEPTOR-ACTIVE COMPOUNDS
    申请人:KIRIN BEER KABUSHIKI KAISHA
    公开号:EP0933354A1
    公开(公告)日:1999-08-04
    A novel calcium receptor active compound having the formula is provided:         Ar1-[CR1 R2]P-X-[CR3R4]q-[CR5R6]-NR7-[CR8R9]-Ar2 wherein: Ar1 is selected from the group consisting of aryl, heteroaryl, bis(arylmethyl)amino, bis(heteroarylmethyl)amino and arylmethyl(heteroarylmethyl)amino; X is selected from the group consisting of oxygen, sulfur, sulfinyl, sulfonyl, carbonyl and amino; R1, R2, R3, R4, R5, R6, R7, R8 and R9 are, for example, hydrogen or alkyl; Ar2 is selected from the group consisting of aryl and heteroaryl; p is an integer of from 0 to 6, inclusive; and, q is an integer of from 0 to 14, inclusive.
    本研究提供了一种具有以下式子的新型钙受体活性化合物: Ar1-[CR1 R2]P-X-[CR3R4]q-[CR5R6]-NR7-[CR8R9]-Ar2 其中 Ar1 选自由芳基、杂芳基、双(芳基甲基)氨基、双(杂芳基甲基)氨基和芳 甲基(杂芳基甲基)氨基组成的组; X 选自氧、硫、亚砜基、磺酰基、羰基和氨基组成的组; R1、R2、R3、R4、R5、R6、R7、R8 和 R9 例如为氢或烷基; Ar2 选自芳基和杂芳基组成的组; p 是 0 至 6(包括 6)的整数;以及 q 是 0 至 14(包括 14)的整数。
  • US6362231B1
    申请人:——
    公开号:US6362231B1
    公开(公告)日:2002-03-26
  • US6750255B2
    申请人:——
    公开号:US6750255B2
    公开(公告)日:2004-06-15
查看更多